Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00612482 · ClinicalTrials.gov registry record · Phase 1

Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education

A Phase 1 study of Substance Abuse, sponsored by Boston Children's Hospital.

Completed
Registry status
Phase 1
Development phase
225
Enrollment target
1
Study location

NCT00612482 is a Phase 1 study of Substance Abuse that has completed, run by Boston Children's Hospital. The registered enrollment target is 225 participants, below the 5,256-participant average among 58 other Substance Abuse trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00612482, a Phase 1 study of Substance Abuse, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
Phase 1
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

Our primary goal is to conduct a pilot study of the effects of a new potential strategy for youth substance abuse prevention - science-based drug education integrated into the high school science curriculum. Through this pilot study we propose to: (1) demonstrate that this new strategy shows promise, and (2) estimate the effect size for the intervention.

Conditions Studied

Interventions

  • OTHER drug prevention curriculum

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2006-12
Est. Completion 2008-01
Phase Phase 1

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00612482

The ClinicalTrials.gov registry entry for NCT00612482 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,256-participant average among 58 other Substance Abuse trials with a reported enrollment target (96% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which drug prevention curriculum is the first listed.

NCT00612482 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00612482 about?

NCT00612482 is a clinical study titled "Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education". Our primary goal is to conduct a pilot study of the effects of a new potential strategy for youth substance abuse prevention - science-based drug education integrated into the high school science curriculum. Through this pilot study we propose to: (1) demonstrate that this new strategy shows promise...

What is the current status of trial NCT00612482?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 225 participants. The study started on 2006-12. Estimated completion is 2008-01.

What conditions does trial NCT00612482 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT00612482?

The interventions under investigation include: drug prevention curriculum (OTHER).

Who is sponsoring clinical trial NCT00612482?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00612482 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.